Medical Science Monitor · 2020 · 10 citations · 26 references
MedicineOncologySurgeryMetastasisSurgical OncologySurvival AnalysisBone MetastasisBone PathologyBone TumorsCancer Survival AnalysisMalignant NeoplasmsTumor ClassificationBone Tumor PrognosisInternational Classification Of DiseasesMultivariable Prediction ModelsMultivariable Risk Prediction ModelsPrognostic Factors AnalysisPrognostic PredictionPrognostic VariablesRandom Forests
BACKGROUND Malignant giant cell tumor of bone (MGCTB) is a rare histological type of malignant tumor that has a high tendency for local relapse and distant metastasis and ultimately leads to a poor prognosis. The purpose of this study was to describe the epidemiological features, identify the prognostic factors, and construct nomograms for patients with MGCTB. MATERIAL AND METHODS Patients with MGCTB that was histologically diagnosed between 1973 and 2014 were selected from the Surveillance, Epidemiology, and End Results (SEER) database as a training set. Survival analysis, Lasso regression, and random forests were used to identify the prognostic variables and establish the nomograms for patients with MGCTB, while an external cohort of 37 patients from our own institution and an external cohort of 163 patients from the SEER database in 2016 were used to validate the generalization performance of the nomograms. RESULTS In total, univariate and multivariable analysis indicated that age, International Classification of Diseases for Oncology, historical stage, primary site, surgery information, radiotherapy, and chemotherapy were independent prognostic variables for overall survival or cause-specific survival. Nomograms based on the multivariable models were built to predict survival, and we achieved a higher C-index in subsequent multidimensional validation. CONCLUSIONS Age, historical stage, and chemotherapy were independent prognostic variables for overall survival and cause-specific survival of MGCTB patients, and radiotherapy and primary site were independent prognostic variables for overall survival. Nomograms based on significant clinicopathological features and clinical experience can be effective in predicting the probability of survival for MGCTB patients.
26
Radiation Therapy for Giant Cell Tumors of Bone
Steven J. Feigenberg, Robert B. Marcus, Robert A. Zlotecki et al. · Clinical Orthopaedics and Related Research · 2003 · 123 citations